301230.SZ

Aug 27, 2026, 10:36 UTC

Hongbo Medicine announced its first-half 2026 results: revenue of 364 million yuan, up 3.31% year-on-year; net profit attributable to shareholders of 28.7294 million yuan, up 16.02%; non-recurring net profit of 6.4603 million yuan, down 67.95%.